|
|
Office of Biotechnology Activities
- Monitors scientific progress in human genetics research in
order to anticipate future developments, including ethical, legal,
and social concerns, in basic and clinical research involving
Recombinant DNA, Genetic Technologies, and Xenotransplantation;
- Manages the operation of, and provides analytical support to, the NIH Recombinant DNA Advisory
Committee, the DHHS Secretary's Advisory Committee on Genetics, Health, and
Society, and the DHHS Secretary's Advisory Committee on Xenotransplantation;
- Coordinates and provides liaison with
Federal and non-Federal national and international organizations
concerned with Recombinant DNA, Human Gene Transfer, Genetic Technologies, and
Xenotransplantation;
- Provides advice to the NIH Director, other Federal agencies, and State
regulatory organizations concerning Recombinant DNA research, Human Gene
Transfer, Genetic Technologies, and Xenotransplantation;
- Responds to requests for information on highly technical matters
and matters of public policy related to Recombinant DNA, Human Gene
Transfer, Genetic Technologies, and Xenotransplantation;
- Develops and implements NIH policies and procedures
for the safe conduct of Recombinant DNA Activities, and Human Gene Transfer;
- Reviews and evaluates the composition of Institutional Biosafety
Committees; and
- Develops registries of activities related to Recombinant
DNA Research and Human Gene Transfer.
|
